nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—Visual acuity reduced—Esomeprazole—Barrett's esophagus	0.033	0.037	CcSEcCtD
Fluocinolone Acetonide—Visual acuity reduced—Omeprazole—Barrett's esophagus	0.033	0.037	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Esomeprazole—Barrett's esophagus	0.0252	0.0283	CcSEcCtD
Fluocinolone Acetonide—Otitis media—Omeprazole—Barrett's esophagus	0.0252	0.0283	CcSEcCtD
Fluocinolone Acetonide—Eye irritation—Esomeprazole—Barrett's esophagus	0.023	0.0258	CcSEcCtD
Fluocinolone Acetonide—Eye irritation—Omeprazole—Barrett's esophagus	0.023	0.0258	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Omeprazole—Barrett's esophagus	0.0182	0.0203	CcSEcCtD
Fluocinolone Acetonide—Dry eye—Esomeprazole—Barrett's esophagus	0.0182	0.0203	CcSEcCtD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.018	0.171	CbGpPWpGaD
Fluocinolone Acetonide—Ear pain—Omeprazole—Barrett's esophagus	0.0167	0.0187	CcSEcCtD
Fluocinolone Acetonide—Ear pain—Esomeprazole—Barrett's esophagus	0.0167	0.0187	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.0161	0.018	CcSEcCtD
Fluocinolone Acetonide—Gastroenteritis—Omeprazole—Barrett's esophagus	0.0161	0.018	CcSEcCtD
Fluocinolone Acetonide—Visual disturbance—Esomeprazole—Barrett's esophagus	0.0151	0.0169	CcSEcCtD
Fluocinolone Acetonide—Visual disturbance—Omeprazole—Barrett's esophagus	0.0151	0.0169	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.0146	0.0164	CcSEcCtD
Fluocinolone Acetonide—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.0146	0.0164	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Omeprazole—Barrett's esophagus	0.0143	0.016	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Omeprazole—Barrett's esophagus	0.0143	0.016	CcSEcCtD
Fluocinolone Acetonide—Diplopia—Esomeprazole—Barrett's esophagus	0.0143	0.016	CcSEcCtD
Fluocinolone Acetonide—Pain in extremity—Esomeprazole—Barrett's esophagus	0.0143	0.016	CcSEcCtD
Fluocinolone Acetonide—Influenza—Omeprazole—Barrett's esophagus	0.0123	0.0138	CcSEcCtD
Fluocinolone Acetonide—Influenza—Esomeprazole—Barrett's esophagus	0.0123	0.0138	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.0115	0.0128	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.0115	0.0128	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Omeprazole—Barrett's esophagus	0.011	0.0123	CcSEcCtD
Fluocinolone Acetonide—Infestation—Omeprazole—Barrett's esophagus	0.011	0.0123	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Esomeprazole—Barrett's esophagus	0.011	0.0123	CcSEcCtD
Fluocinolone Acetonide—Infestation—Esomeprazole—Barrett's esophagus	0.011	0.0123	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Omeprazole—Barrett's esophagus	0.0103	0.0116	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Esomeprazole—Barrett's esophagus	0.0103	0.0116	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.0103	0.0976	CbGpPWpGaD
Fluocinolone Acetonide—Rhinitis—Omeprazole—Barrett's esophagus	0.0099	0.0111	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Esomeprazole—Barrett's esophagus	0.0099	0.0111	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.0097	0.0109	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.0097	0.0109	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Esomeprazole—Barrett's esophagus	0.00951	0.0107	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Omeprazole—Barrett's esophagus	0.00951	0.0107	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Omeprazole—Barrett's esophagus	0.00922	0.0103	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Esomeprazole—Barrett's esophagus	0.00922	0.0103	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.0089	0.00996	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.0089	0.00996	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Esomeprazole—Barrett's esophagus	0.00872	0.00977	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Omeprazole—Barrett's esophagus	0.00872	0.00977	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Omeprazole—Barrett's esophagus	0.00865	0.00969	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Esomeprazole—Barrett's esophagus	0.00865	0.00969	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Esomeprazole—Barrett's esophagus	0.00859	0.00962	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Omeprazole—Barrett's esophagus	0.00859	0.00962	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Omeprazole—Barrett's esophagus	0.00841	0.00942	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00841	0.00942	CcSEcCtD
Fluocinolone Acetonide—Back pain—Esomeprazole—Barrett's esophagus	0.00831	0.00931	CcSEcCtD
Fluocinolone Acetonide—Back pain—Omeprazole—Barrett's esophagus	0.00831	0.00931	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Esomeprazole—Barrett's esophagus	0.0081	0.00907	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Omeprazole—Barrett's esophagus	0.0081	0.00907	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Omeprazole—Barrett's esophagus	0.00772	0.00865	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Esomeprazole—Barrett's esophagus	0.00772	0.00865	CcSEcCtD
Fluocinolone Acetonide—Cough—Esomeprazole—Barrett's esophagus	0.0075	0.0084	CcSEcCtD
Fluocinolone Acetonide—Cough—Omeprazole—Barrett's esophagus	0.0075	0.0084	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—SLC9A1—Barrett's esophagus	0.00746	0.0709	CbGpPWpGaD
Fluocinolone Acetonide—Arthralgia—Omeprazole—Barrett's esophagus	0.00732	0.00819	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Esomeprazole—Barrett's esophagus	0.00732	0.00819	CcSEcCtD
Fluocinolone Acetonide—Infection—Esomeprazole—Barrett's esophagus	0.00697	0.0078	CcSEcCtD
Fluocinolone Acetonide—Infection—Omeprazole—Barrett's esophagus	0.00697	0.0078	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00688	0.0077	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00688	0.0077	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00686	0.0652	CbGpPWpGaD
Fluocinolone Acetonide—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00639	0.00716	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00639	0.00716	CcSEcCtD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CRTC1—Barrett's esophagus	0.00607	0.0577	CbGpPWpGaD
Fluocinolone Acetonide—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00605	0.00678	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00605	0.00678	CcSEcCtD
Fluocinolone Acetonide—Pain—Esomeprazole—Barrett's esophagus	0.006	0.00672	CcSEcCtD
Fluocinolone Acetonide—Pain—Omeprazole—Barrett's esophagus	0.006	0.00672	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00554	0.00621	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Omeprazole—Barrett's esophagus	0.00554	0.00621	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00542	0.0515	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00517	0.00579	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00517	0.00579	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Omeprazole—Barrett's esophagus	0.00496	0.00556	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Esomeprazole—Barrett's esophagus	0.00496	0.00556	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Esomeprazole—Barrett's esophagus	0.0048	0.00537	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Omeprazole—Barrett's esophagus	0.0048	0.00537	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Endothelins—SLC9A1—Barrett's esophagus	0.00466	0.0443	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Omeprazole—Barrett's esophagus	0.00464	0.00519	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Esomeprazole—Barrett's esophagus	0.00464	0.00519	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Esomeprazole—Barrett's esophagus	0.00446	0.00499	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Omeprazole—Barrett's esophagus	0.00446	0.00499	CcSEcCtD
Fluocinolone Acetonide—Rash—Esomeprazole—Barrett's esophagus	0.00442	0.00495	CcSEcCtD
Fluocinolone Acetonide—Rash—Omeprazole—Barrett's esophagus	0.00442	0.00495	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Esomeprazole—Barrett's esophagus	0.00442	0.00495	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Omeprazole—Barrett's esophagus	0.00442	0.00495	CcSEcCtD
Fluocinolone Acetonide—Headache—Esomeprazole—Barrett's esophagus	0.00439	0.00492	CcSEcCtD
Fluocinolone Acetonide—Headache—Omeprazole—Barrett's esophagus	0.00439	0.00492	CcSEcCtD
Fluocinolone Acetonide—Nausea—Esomeprazole—Barrett's esophagus	0.00417	0.00467	CcSEcCtD
Fluocinolone Acetonide—Nausea—Omeprazole—Barrett's esophagus	0.00417	0.00467	CcSEcCtD
Fluocinolone Acetonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Barrett's esophagus	0.00349	0.0332	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.00303	0.0288	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—Barrett's esophagus	0.00268	0.0255	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—CYP26A1—Barrett's esophagus	0.00256	0.0244	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptors—PPARG—Barrett's esophagus	0.00226	0.0215	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00201	0.0192	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—BMP4—Barrett's esophagus	0.00194	0.0185	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00178	0.017	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.00177	0.0168	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—RELA—Barrett's esophagus	0.00166	0.0158	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.00159	0.0152	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Endoderm Differentiation—APC—Barrett's esophagus	0.00147	0.014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00147	0.014	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.00143	0.0136	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.00116	0.0111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.00109	0.0103	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.00106	0.01	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	0.000987	0.00939	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000936	0.0089	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	0.00093	0.00885	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000908	0.00863	CbGpPWpGaD
Fluocinolone Acetonide—Triamcinolone—PTGS2—Barrett's esophagus	0.000903	0.436	CrCbGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—PPARG—Barrett's esophagus	0.000843	0.00802	CbGpPWpGaD
Fluocinolone Acetonide—Betamethasone—PTGS2—Barrett's esophagus	0.000739	0.357	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000689	0.00656	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GAST—Barrett's esophagus	0.000659	0.00627	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGES—Barrett's esophagus	0.000653	0.00621	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—AP-1 transcription factor network—TP53—Barrett's esophagus	0.000648	0.00616	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	0.000571	0.00543	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—HGF—Barrett's esophagus	0.000561	0.00533	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000556	0.00529	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP26A1—Barrett's esophagus	0.000495	0.00471	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—SST—Barrett's esophagus	0.000452	0.0043	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—NR1I2—Barrett's esophagus	0.000451	0.00429	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—Barrett's esophagus	0.00043	0.208	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.00041	0.0039	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GAST—Barrett's esophagus	0.000389	0.0037	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000366	0.00348	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC9A1—Barrett's esophagus	0.000357	0.00339	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000308	0.00293	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000288	0.00274	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SST—Barrett's esophagus	0.000267	0.00254	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—TP53—Barrett's esophagus	0.000188	0.00179	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000176	0.00167	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPARG—Barrett's esophagus	0.000163	0.00155	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—PPARG—Barrett's esophagus	0.000148	0.00141	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APC—Barrett's esophagus	0.000141	0.00134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—Barrett's esophagus	0.000128	0.00122	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RELA—Barrett's esophagus	0.00011	0.00105	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL8—Barrett's esophagus	0.000104	0.000989	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TP53—Barrett's esophagus	6.38e-05	0.000607	CbGpPWpGaD
